Early Access

10-KPeriod: FY2013

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2013

Filed February 12, 2014For Securities:UNH

Summary

UnitedHealth Group (UNH) reported strong performance in its 2013 10-K filing, demonstrating significant revenue growth driven by both its UnitedHealthcare and Optum segments. The company's diversified business model, encompassing health benefits and health services, contributed to an 11% increase in total revenues to $122.5 billion. Earnings from operations grew by 4% to $9.6 billion. A key strategic move mentioned is the upcoming business realignment in 2014, which aims to further capitalize on Optum's technology and business processing capabilities. The company also highlighted its proactive approach to managing medical costs and its ongoing efforts to adapt to the evolving healthcare landscape, including the impact of the Patient Protection and Affordable Care Act. Investors would note the company's continued expansion, particularly through acquisitions like Amil in Brazil, which significantly boosted international revenue. The Optum segment showed particularly robust growth, with revenues up 26% and earnings from operations up 61%, underscoring the strategic importance of its health services arm. The filing also details the company's capital management strategies, including share repurchases and dividend increases, reflecting a commitment to shareholder returns.

Financial Statements
Beta
Revenue$122.49B
Cost of Revenue$2.89B
Gross Profit$119.60B
SG&A Expenses$18.94B
Operating Expenses$112.87B
Operating Income$9.62B
Interest Expense$708.00M
Net Income$5.63B
EPS (Basic)$5.59
EPS (Diluted)$5.50
Shares Outstanding (Basic)1.01B
Shares Outstanding (Diluted)1.02B

Key Highlights

  • 1Consolidated revenues increased by 11% to $122.5 billion in 2013, driven by growth in both UnitedHealthcare and Optum segments.
  • 2Earnings from operations increased by 4% to $9.6 billion, with Optum showing significant growth of 61%.
  • 3UnitedHealthcare experienced organic medical enrollment growth of 4.5 million people, including 2.9 million through the TRICARE contract.
  • 4OptumRx successfully insourced pharmacy services for 12 million UnitedHealthcare customers.
  • 5The company acquired the remaining shares of Amil in Brazil for $1.5 billion, increasing its ownership to 90% and boosting international revenues.
  • 6UnitedHealth Group returned significant capital to shareholders through dividends ($1.1 billion) and share repurchases ($3.2 billion).
  • 7The company proactively managed its medical care ratio, which increased slightly to 81.5%, and discussed strategies to navigate changes brought by the Affordable Care Act.

Frequently Asked Questions